Search

Your search keyword '"Sepulcri C"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Sepulcri C" Remove constraint Author: "Sepulcri C"
38 results on '"Sepulcri C"'

Search Results

1. Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence

2. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

3. Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study

4. Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19

5. Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity

6. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

8. Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients.

9. COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospital.

10. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.

11. Treating influenza with neuraminidase inhibitors: an update of the literature.

12. Tuberculosis Infection Control: Experiences and Considerations from a Web Based Tool Implementation.

13. Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring.

14. Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: Incidence, clinical management, and outcome.

15. Frequency of Detection of Candida auris Colonization Outside a Highly Endemic Setting: What Is the Optimal Strategy for Screening of Carriage?

17. Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.

18. Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders.

19. Skin and soft tissue infections due to rapidly growing mycobacteria.

20. Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19.

22. Neutralizing monoclonal antibodies for early treatment of hospital-acquired SARS-CoV-2 infection in hematologic patients.

23. Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit.

24. Isavuconazole for COVID-19-Associated Invasive Mold Infections.

25. Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey.

26. Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors.

27. Mind the gap: IgG4-related disease mimicking infectious cerebral mass lesions.

28. Mycobacterium tuberculosis Surgical Site Infection after Cardiac Surgery in the COVID-19 Era: A Case Report.

29. The Role of PCSK9 in Infectious Diseases.

30. Recent advances and future perspectives in the pharmacological treatment of Candida auris infections.

31. The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.

32. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy.

34. Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy.

35. Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance.

36. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.

37. Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales .

38. Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis.

Catalog

Books, media, physical & digital resources